SCHEMBL28948874

SCHEMBL28948874

O=C(CBr)NCc1c(F)cccc1F

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
MEN1 O00255 1/20 0.44
P2RX7 Q99572 5/20 0.43
MAPK14 Q16539 1/20 0.42
HTT P42858 1/20 0.41
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
NPC1 O15118 2/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KDM4E B2RXH2 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23052072 0.81 CYP1A2 (0.50) KMT2AMEN1P2RX7MAPK14ALDH1A1
SCHEMBL4034946 0.81 ALDH1A1 (0.51) KMT2AMEN1P2RX7MAPK14HTT
SCHEMBL23134945 0.80 HPGD (0.57) KMT2AMEN1ALDH1A1SMN1; SMN2NPC1
SCHEMBL32665423 0.80 HPGD (0.43) KMT2AMEN1P2RX7ALDH1A1SMN1; SMN2
SCHEMBL28822084 0.79 LMNA (0.53) KMT2AP2RX7HTTALDH1A1SMN1; SMN2
SCHEMBL8696462 0.79 KMT2A (0.42) KMT2AMEN1P2RX7MAPK14HTT
SCHEMBL15295190 0.79 CYP3A4 (0.51) P2RX7ALDH1A1HPGD
SCHEMBL3557822 0.79 CYP1A2 (0.48) KMT2AMEN1P2RX7MAPK14ALDH1A1
SCHEMBL22803047 0.77 MCL1 (0.58) KMT2AMEN1P2RX7MAPK14HTT
SCHEMBL2997305 0.77 P2RX7 (0.55) KMT2AMEN1P2RX7HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787145-B Benzamide derivatives as transforming growth factor-beta receptor I/ALK5 inhibitors 阿戈麦布西班牙股份有限公司 2024-03-26 CN disclosed
CN-114787145-A Benzamide derivatives as transforming growth factor-beta receptor I/ALK5 inhibitors 奥里戈生物制药有限公司 2022-07-22 CN disclosed